[HTML][HTML] Efficacy of Buzhong Yiqi decoction (补中益气汤) on benign prostatic hyperplasia and its possible mechanism

JIA Lihua, H Kuang, XU Yuan - Journal of Traditional Chinese …, 2023 - ncbi.nlm.nih.gov
OBJECTIVE: To explored the mechanism of Buzhong Yigi decoction (补中益气汤BZYQD) in
inhibiting prostatic cell proliferation effect. METHODS: The compounds of BZYQD consisted …

Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway

Y Liu, R Shao, T Suo, J Zhu, E Liu, Y Wang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Inflammation plays a critical role during benign prostatic
hyperplasia (BPH) development. Danzhi qing'e (DZQE) decoction is a traditional Chinese …

[HTML][HTML] Exploring the mechanism of action of Qian Lie Xing Fang during the treatment of benign prostatic hyperplasia via network pharmacology and molecular …

J Xiang, Z Li, C Wang - Medicine, 2023 - journals.lww.com
This study aimed to explore the historical research progress on benign prostatic hyperplasia
from the perspective of traditional Chinese medicine theory and the treatment of benign …

Clinical observation on ziyin tongbi decoction in treating benign prostatic hyperplasia

J Guo, CS Song, Q Han - Zhongguo Zhong xi yi jie he za zhi …, 2008 - europepmc.org
Objective To evaluate the efficacy and safety of Ziyin Tongbi Decoction (ZTD) in treating
benign prostatic hyperplasia (BPH). Methods Adopting randomized positive controlled …

The mechanism of Lingze tablets in the treatment of benign prostatic hyperplasia based on network pharmacology and molecular docking technology

C Shaofeng, L Chunxu, G Qiang - Andrologia, 2022 - Wiley Online Library
Lingze tablets has been used as a drug in the treatment of kidney deficiency‐dampnes shea‐
stasis type benign prostatic hyperplasia (BPH) in Traditional Chinese Medicine, and it was …

Anti-testicular Inflammation Mechanism of Wuzi Yanzongwan Based on Network Pharmacology

K HU, Y XU, D LIU, L CUI… - Chinese Journal of …, 2022 - pesquisa.bvsalud.org
ObjectiveTo explore the anti-testicular inflammation mechanism of Wuzi Yanzongwan
through network pharmacological analysis and experimental verification. MethodThe active …

The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR …

H Geum-Lan, KIM Tae-Won, LEE Hui-Ju… - Chinese Journal of …, 2022 - Elsevier
Benign prostatic hyperplasia (BPH) is a chronic male disease characterized by the enlarged
prostate. Celtis chosenianaNakai (C. choseniana) is medicinally used to alleviate pain …

[HTML][HTML] Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-β/Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats

W Chen, X Huang, A Peng, T Chen, R Yang… - Evidence-Based …, 2019 - hindawi.com
Background. Kangquan Recipe (KQR) is a traditional Chinese medicine compound made by
our research group for the treatment of benign prostatic hyperplasia (BPH). Whether KQR …

Effects of Kangquan Recipe (康泉方) on sex steroids and cell proliferation in rats with benign prostatic hyperplasia

Y Huang, J Du, Z Hong, Z Chen, J Wu… - Chinese journal of …, 2009 - Springer
Objective To investigate the effects of Kangquan Recipe (康泉方, KQR) on sex steroids and
cell proliferation in an experimental benign prostatic hyperplasia (BPH) model in rats …

Study on mechanism of Rhei Radix et Rhizoma-Persicae Semen in treatment of adenomyosis based on network pharmacology

L Zi, Z Jia-Qiong, FU Xian-Yun, W Wei… - Zhongguo Zhong yao …, 2020 - europepmc.org
The aim of this paper was to screen the active targets of Rhei Radix et Rhizoma and
Persicae Semen in the treatment of adenomyosis (AM) by means of network pharmacology …